LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 259 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 3.43 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $1,507,000 | +2.8% | 11,108 | +108.0% | 0.59% | +56.3% |
| Q3 2018 | $1,466,000 | +208.0% | 5,341 | +85.0% | 0.38% | +514.8% |
| Q1 2018 | $476,000 | -52.9% | 2,887 | -60.9% | 0.06% | -54.5% |
| Q4 2017 | $1,011,000 | -28.5% | 7,387 | -28.9% | 0.13% | -28.0% |
| Q3 2017 | $1,413,000 | +97.9% | 10,385 | +76.5% | 0.19% | +104.4% |
| Q2 2017 | $714,000 | -64.3% | 5,883 | -68.8% | 0.09% | -64.3% |
| Q1 2017 | $1,998,000 | -65.6% | 18,886 | -67.0% | 0.26% | -50.7% |
| Q4 2016 | $5,807,000 | -17.1% | 57,158 | -16.8% | 0.52% | -5.7% |
| Q3 2016 | $7,009,000 | +31.3% | 68,677 | +53.4% | 0.55% | +38.0% |
| Q2 2016 | $5,338,000 | +11.2% | 44,756 | -0.2% | 0.40% | +16.1% |
| Q1 2016 | $4,801,000 | +105.3% | 44,838 | +107.9% | 0.34% | +111.1% |
| Q4 2015 | $2,338,000 | – | 21,567 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KNOTT DAVID M | 1,249,766 | $58,726,504,000 | 11.17% |
| BVF INC/IL | 1,108,763 | $52,101,000 | 10.82% |
| GROW Partners, LLC | 132,500 | $6,226,000 | 5.58% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 936,825 | $44,021,000 | 2.73% |
| First Light Asset Management, LLC | 76,366 | $3,588,000 | 2.45% |
| Healthcare Value Capital, LLC | 50,000 | $2,350,000 | 2.27% |
| OBERWEIS ASSET MANAGEMENT INC/ | 168,337 | $7,910,000 | 2.17% |
| RK Capital | 174,283 | $8,190,000 | 1.67% |
| Nichols Asset Management LLC | 133,368 | $6,267,000 | 1.30% |
| ASHFORD CAPITAL MANAGEMENT INC | 108,289 | $5,089,000 | 1.09% |